Filing Flows › Zomedica (ZOMDF) › Q4 2025
Zomedica (ZOMDF) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 16, 2026
Zomedica (ZOMDF) reported revenue of $10.5M for the fourth quarter 2025 (Q4 2025), +33% from a year earlier and +29% from the quarter before. Operating margin was -49.3%, net loss $4.5M (43.3% of revenue).
Zomedica, Q4 2025: revenue $10.5M (+33% year over year), operating margin -49.3%, net loss $4.5M, operating cash flow −$899K. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.5M | +29% | +33% |
| Operating profit | −$5.2M | — | — |
| Net earnings | −$4.5M | — | — |
| Operating cash flow | −$899K | — | — |
What changed
Revenue was $10.5M in Q4 2025, up 33% year over year and up 29% from the previous quarter. Consumables was the largest line at 53% of revenue.
Gross margin was 68.5%, down 1.8 points from a year earlier. Operating costs exceeded revenue by $5.2M, an operating margin of -49.3%. Operating expenses fell 10% while revenue rose 33%. The quarter ended with a net loss of $4.5M, narrower than the previous quarter's $6.1M loss.
Operating cash flow was −$899K. Non-cash charges added back $1.9M of depreciation and amortization and $727K of share-based compensation. Working capital and other items added $1.0M. Capital expenditures of $107K exceeded it, leaving free cash flow of −$1.0M.
Questions
What was Zomedica's revenue in the fourth quarter 2025?
Zomedica (ZOMDF) reported revenue of $10.5M for the fourth quarter 2025 (Q4 2025), +33% from a year earlier and +29% from the quarter before.
Was Zomedica profitable in the fourth quarter 2025?
Operating loss was $5.2M (-49.3% of revenue) and net loss $4.5M.
Source: Zomedica 10-K on SEC EDGAR.